CLRB

Cellectar Biosciences, Inc.

Healthcare · Biotechnology

$183.81 sample

+0.16 (+0.09%) 1D

Market cap

$616.1B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-16

Alerts

8

Price$183.81 +2.24% 3M daily closessample

196.40179.55

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13INSInsider sell: 10% owner
Oct 07INSInsider sell: EVP, Operations
Sep 28INSInsider sell: Director
Sep 22INSInsider buy: Chief Executive Officer
Sep 16SECForm 144 filed
Sep 07INSInsider buy: Chief Executive Officer
Aug 27INSInsider sell: Chief Executive Officer
Aug 21INSInsider buy: 10% owner

Sign up to see the real CLRB record →

Company facts

SEC EDGAR registration

Name: Cellectar Biosciences, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -22sample, -100 to +100
Reporting currency: USD

Who is positioning in CLRB

sample

Insiders: 15 insider transactions over 90 days, net selling, $578.6M
Congress: 1 members traded over 90 days
Institutions · 13F: 16 funds hold $14.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$14.0B +15.1% y/y

Q4 2024Q3 2026

Inventory$8.8B +21.0% y/y

Q4 2024Q3 2026

Accounts receivable$6.5B +16.1% y/y

Q4 2024Q3 2026

Total debt$18.0B +22.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $61.9B -9.8% 3M
Sample peer B: $472.4B -3.8% 3M
Sample peer C: $83.2B +8.9% 3M
Sample peer D: $496.2B -3.8% 3M
Sample peer E: $226.3B -8.3% 3M